Vice President of Sales

From 18,000 HCPs to a prioritized Engagement Playbook. Read Time: 11 min EXECUTIVE SUMMARY From Fragmented Data to Executable Field Strategy A pharmaceutical commercial team preparing for a major product launch faced a targeting problem at scale: 18,000+ healthcare professionals in scope, finite field capacity, and no systematic way to decide who to reach, through which channel, with what message, and when. Lynx Analytics was engaged to turn that fragmented data landscape into a prioritized, actionable engagement system. The legacy approach relied on instinct and inherited call lists. Prescription records, digital engagement histories, clinical publication data, and territory visit logs all existed - but in isolation. Without a way to synthesize that data into something a field rep could act on in the fifteen minutes before a call, it went unused. The result: 11% email open rates and 90% of target HCPs going unvisited in the prior three months. Lynx Analytics designed and built a guided four-step omnichannel engagement platform - anchored by an AI co-pilot and a clinically grounded persona framework - that takes a commercial team from raw territory data to a fully executable engagement plan in a single workflow session. | KEY IMPACT The client moved from instinct-driven, undifferentiated outreach to a persona-stratified engagement model with executional materials ready to take into the field - closing the gap between data and action at launch speed. | An Information-Rich, Insight-Poor Environment Pharmaceutical product launches represent some of the most resource-intensive commercial operations in life sciences - and some of the most time-sensitive. The window in which a new brand establishes prescribing patterns is narrow, and the cost of poorly targeted field engagement during that window compounds quickly. Digital channels are saturated, field reps carry limited call capacity, and HCPs are notoriously difficult to reach. For the client's commercial team, the data infrastructure to make smarter decisions already existed. The gap was not information - it was synthesis. Translating prescription records, engagement histories, and territory data into prioritized, channel-appropriate actions required analytical capabilities that neither field reps nor brand managers were equipped to perform - nor should they have to be. CHALLENGE: Three Problems Compounding at Launch An Addressable Market Too Large to Engage Well With more than 18,000 HCPs theoretically in scope, blanket engagement was not an option. The absence of a principled prioritization framework meant resources defaulted to legacy call lists rather than opportunity. At 90% unvisited in the prior three months, entire high-potential segments were going dark. Data That Existed But Couldn't Be Acted On Prescription records, digital engagement histories, clinical publication data, and territory visit logs all sat in separate systems. There was no mechanism to synthesize them into specific, timely guidance a field rep could use in the fifteen minutes before a call. Channel Performance That Signaled a Targeting Problem An 11% email open rate pointed not to content failure but to audience misalignment: the right message was reaching the wrong people, or reaching them through the wrong channel at the wrong moment. SOLUTION: A Guided Workflow, Not an Open Dashboard The foundational design decision was to build a linear, opinionated workflow rather than a configurable analytics environment. The four steps - Engagement Planner, Smart List, List Analysis, and Dynamic Engagement Playbook - map directly to the sequence of decisions a commercial team actually makes: who matters, who to target now, what do I know about this group, and what exactly should I do? Faced with an open analytics environment, users explored rather than acted. The guided workflow routes them toward Step 4 - the Engagement Playbook - rather than leaving them in Step 1. LynxScribe: Conversational AI Inside a Structured Flow Lynx Analytics embedded a conversational AI co-pilot, LynxScribe, directly into the list-refinement step: contextually aware of where the user is in the workflow and what they've already built. A rep can ask LynxScribe to "narrow this to the top 20% most likely to be early adopters" and receive a refined list without touching a segmentation model. Natural language for the complex analytical moments; structured interface everywhere else. HCP Personas as the Organizing Principle Rather than exposing raw segmentation dimensions, Lynx Analytics built the product around four clinically meaningful HCP personas: Guarded Gatekeeper, Peer Influencer, Steady Prescriber, and Quick Starter. Each is grounded in scored attributes spanning Treatment Mindset, Brand Affinity, and Digital Engagement - creating a shared vocabulary that bridges individual rep decisions and aggregate engagement strategy. "Natural language for the complex analytical moments; structured interface everywhere else." The Playbook: Designed to Be Taken Into the Field Lynx Analytics designed the workflow to conclude with something a rep can act on immediately: per-persona engagement recommendations, ready-to-send email drafts with clinically aligned messaging, face-to-face talk tracks, and explicit Do/Avoid guidelines by persona. Iteration reduced the output to three to five prioritized, channel-specific actions per persona - with executional detail sufficient to act without further interpretation. IMPLEMENTATION: How It Was Built Lynx Analytics developed the platform using a structured, iterative approach - starting with the workflow logic and persona framework, then layering in LynxScribe and the Omnichannel Measurement dashboard. The data infrastructure on the client side was sufficiently mature to allow the team to focus on product design and analytical modeling rather than data engineering. Early iterations of the Engagement Playbook were comprehensive, covering every possible recommendation for every persona. User testing revealed these went unread. Subsequent iterations reduced the output to three to five prioritized actions per persona - a design choice that measurably improved field adoption. OMNICHANNEL MEASUREMENT: Scored Priority Actions The measurement layer closes the loop between engagement and outcome. Rather than surfacing insights and leaving prioritization to the user, the dashboard presents three ranked Priority Actions per session - each assigned a quantified estimated lift in points. Examples from the platform: Scoring creates a clear hierarchy where the underlying data does not provide one - giving teams a practical basis for deciding what to do next. IMPACT & RESULTS: From Data to Decision - In a Single Session Brand teams can now move from raw territory data to a prioritized, persona-stratified engagement plan - complete with executional materials - within a single workflow session. The platform eliminates the analytical translation layer that previously sat between data and action, putting engagement decisions in the hands of the field reps and brand managers who need to act on them. "The platform eliminates the analytical translation layer that previously sat between data and action." Platform at a Glance | 18K+ HCPs in scope at launch | 4 HCP personas grounded in clinical scoring | 4 Guided workflow steps to a complete engagement plan | 3-5 Prioritized actions per persona in the Playbook | KEY RESULTS | OUTCOME | IMPACT | | Guided four-step workflow | Commercial teams move from territory data to an executable engagement plan in a single session, eliminating multi-tool fragmentation. | | LynxScribe AI co-pilot | Complex segmentation tasks completed in plain language, without requiring analytical expertise from field users. | | HCP persona framework | Shared vocabulary across field reps, brand managers, and analytics teams - enabling consistent strategy execution at scale. | | Dynamic Engagement Playbook | Per-persona email drafts, talk tracks, and Do/Avoid guidelines ready to deploy from day one. | | Scored Priority Actions | Clear ranked hierarchy for next-best actions, removing decision paralysis when presented with equivalent-seeming data. | | Omnichannel Measurement layer | Closed-loop visibility into engagement performance, with quantified lift estimates per action. | CONCLUSION: Closing the Distance Between Data and Decision This project demonstrates that the hard problem in commercial analytics is rarely the data - it's the distance between the data and the decision-maker. Lynx Analytics closed that distance by designing for the actual workflow of a field rep under launch pressure: not a dashboard to explore, but a system that delivers a prioritized, executable plan and gets out of the way. The integration of conversational AI into a structured workflow - rather than as a standalone feature - points toward a broader design principle: AI is most useful in commercial contexts when it is contextually embedded, appropriately scoped, and invisible enough that the user's attention stays on the decision, not the tool. | For pharmaceutical commercial teams navigating launch complexity, the Lynx Analytics platform demonstrates that the path to better engagement decisions is not more data - it is a smarter, guided path through the data that already exists. | The baseline metrics - 90% of HCPs unvisited, 11% email open rates - now serve as the foundation from which the impact of persona-appropriate, channel-optimized outreach can be rigorously tracked. As campaigns run and the Omnichannel Measurement layer captures outcomes, the client's commercial team gains not just better execution today, but a continuously improving engagement intelligence system for every launch that follows.

Lynx Analytics introduces Lumen, an Agentic AI framework to improve decision-making in life sciences. LOS GATOS, Calif., Jan. 14, 2026 /PRNewswire/ - Lynx Analytics today announced Lumen, a specialized Agentic AI framework designed to help pharmaceutical and biotech organizations generate strategic, decision-ready insights from complex scientific and commercial information. Built specifically for life sciences workflows, Lumen enables companies to deploy AI agents across a wide range of real-world use cases - from rapidly distilling lengthy clinical or market research documents, to generating dynamic HCP personas and personalized engagement strategies, to powering natural-language analytics that explain drivers behind forecast shifts or market performance. The framework brings accumulated best practices from multiple Agentic AI deployments across global pharma companies. One of the first real-world applications built on Lumen is IlluminAI - a customized decision-support solution developed in collaboration with the International Oncology team at AstraZeneca. "The introduction of the IlluminAI assistant at AstraZeneca has streamlined how we approach brand launch planning. Our teams can ask natural-language questions about forecast drivers and receive insights grounded in patient forecast models and revenue data. IlluminAI is now embedded in planning cycles across International Markets. We look forward to continuing our partnership with Lynx Analytics to further develop IlluminAI." said Christos Georgiou, Oncology Launch & Business Excellence Director, International Markets at AstraZeneca. Ankit Agrawal, Director of Client Engagement at Lynx Analytics, added: "Lumen is the foundation for Lynx's next generation of Agentic AI in pharma, already deployed across priority commercial and medical use cases. At AstraZeneca, IlluminAI puts this into practice for the International Oncology team, where agents connect patient forecast models and revenue data to pinpoint the key drivers and assumptions behind each forecast, explained in simple, easy-to-understand language" Lumen enables decision-support agents such as campaign-planning copilots that forecast ROI and generate targeted content; patient-support agents that deliver compliant, 24/7 medical information; and clinical-trial intelligence agents that surface relevant insights and help teams monitor study challenges in real time. All insights include linked citations for transparency, giving teams audit-ready evidence behind each recommendation. Lumen is now available to pharmaceutical and life sciences organizations seeking to elevate strategic planning, accelerate analysis, and deploy responsible AI at scale. About Lynx Analytics Lynx Analytics is a global AI and data-science company specializing in life sciences applications, graph analytics, and Agentic AI systems. The company partners with leading pharmaceutical organizations to transform complex data into strategic advantage.